Key takeaways:
Lantus (insulin glargine) is a long-acting insulin that has been around for over 20 years. It’s available in a vial and SoloStar injection pen.
Semglee (insulin glargine-yfgn) is an interchangeable biosimilar to Lantus. This means it provides similar benefits, and you can switch from one insulin to the other. Semglee also comes in a vial and injection pen.
Brand-name Semglee has been discontinued, but an unbranded version is still available. There are many ways to save on Lantus and unbranded Semglee. GoodRx can help you access Lantus at an exclusive cash price of $35 per month. Manufacturer savings cards and patient assistance programs are also available.
Save on related medications
If you’re living with diabetes and insulin is part of your treatment plan, there are several long-acting insulin options to choose from. Lantus (insulin glargine) has been around the longest. But there’s also a Lantus alternative called Semglee (insulin glargine-yfgn) on the market.
While Lantus and Semglee aren’t exactly the same, you can substitute one for the other. So, how do Lantus and Semglee compare? We discuss seven things you should know below.
Note: Brand-name Semglee has been discontinued. But an unbranded version, called insulin glargine-yfgn, is still available. For simplicity, this article refers to it as Semglee.
1. Semglee is interchangeable with Lantus
Lantus is a long-acting insulin that has been around for over 20 years. It’s also a biologic medication. That means it’s made using a living system and regulated differently from chemical-based medications, such as blood pressure pills.
Lantus is a brand-name insulin. Manufacturers can’t make copies — or generic versions — of biologics. Instead, they can make biosimilars. Biosimilars are biologics that are highly similar to another FDA-approved biologic.
Semglee is a long-acting insulin that was first approved in June 2020. In July 2021, it became the first interchangeable biosimilar to Lantus. This means it’s highly similar to Lantus, and it has gone through additional studies to show that you can switch between products without issues.
Since it’s interchangeable, your pharmacist can more easily substitute Semglee for Lantus without contacting your prescriber first. This is similar to how your pharmacist may switch you from a brand-name medication to a generic.
Semglee and another insulin called Rezvoglar (insulin glargine-aglr) are both interchangeable biosimilars to Lantus. Basaglar (insulin glargine) is considered a follow-on biologic version of Lantus. That’s because it was approved before insulin needed to go through the biosimilar approval pathway. Basaglar isn’t considered to be interchangeable with Lantus.
2. Lantus and Semglee work the same way for diabetes
Lantus and Semglee are both types of insulin. Insulin is an important hormone in your body. It helps regulate your blood glucose (blood sugar) levels and prevents them from getting too high. Some people with diabetes may need to supplement insulin if they don’t make enough or if their body is resistant to the insulin they make.
Long-acting insulins, such as Lantus and Semglee, are slowly released and absorbed by the body, providing a steady amount of insulin for up to 24 hours. They work in the background to manage your blood sugar levels, even when you’re not eating.
Lantus or Semglee may be used in combination with faster-acting insulins throughout the day to help keep your blood sugar levels within your target range.
3. Lantus and Semglee are available in the same dosage forms and are given the same way
Both Lantus and Semglee are administered as subcutaneous (under-the-skin) injections once daily. It doesn’t matter what time of day, but it should be at the same time every day.
Injection sites include the thigh, stomach area, and upper arm. It’s recommended to rotate where you inject each time to avoid hard lumps or fatty deposits from forming. Always use a new needle with each injection — don’t reuse needles.
How much insulin you should inject is individualized to your specific needs. Follow your prescriber’s instructions to ensure you’re giving yourself the correct dose.
Lantus and Semglee are available in vials and prefilled injection pens. Injection pens can be a good option if you have difficulty drawing your insulin dose from a vial.
4. Lantus and Semglee are similarly effective for diabetes
Semglee contains a slightly different form of insulin glargine called insulin glargine-yfgn. But since it’s a biosimilar to Lantus, there are no clinically meaningful differences between the two products. This means that Semglee is just as effective as Lantus in managing blood sugar levels. You should expect similar results if you switch from Lantus to Semglee (or vice versa).
Since Lantus and Semglee provide similar benefits, factors such as insurance coverage and cost may ultimately determine which option is right for you. More on that later.
5. Lantus and Semglee can cause similar side effects
As with all insulins, Lantus and Semglee can cause side effects, which should be similar between products. Examples of these include:
Low blood sugar (hypoglycemia)
Hard lumps or fatty deposits (lipodystrophy)
Injection site reactions, such as swelling, redness, and pain
Itchy skin
Swelling in hands or feet
Rash
Low potassium levels (hypokalemia)
Some side effects can be avoided or minimized by rotating injection sites and carefully monitoring your blood sugar levels.
6. Lantus and Semglee have similar interactions
Lantus and Semglee can both interact with other medications that lower blood sugar levels. These combinations can increase the risk of hypoglycemia. Examples include:
Sulfonylureas, such as glipizide (Glucotrol XL)
Meglitinides (glinides), such as repaglinide
Glucagon-like peptide-1 receptor agonists, such as semaglutide (Ozempic, Wegovy, Rybelsus)
Fluoroquinolone antibiotics, such as ciprofloxacin
Sulfa antibiotics, such as sulfamethoxazole / trimethoprim (Bactrim)
There are also some medications and supplements that can increase blood sugar levels, making Lantus and Semglee less effective. Examples include corticosteroids and antipsychotic medications.
Make sure your prescriber and pharmacist know all of the medications you’re taking. This includes over-the-counter products and supplements. This can help you avoid or manage potential interactions.
7. Lantus and Semglee are both available as unbranded insulins
Lantus is available as a brand-name insulin product, while brand-name Semglee has been discontinued. However, both insulins are available as unbranded products. This is similar to the concept of authorized generics.
The unbranded biologic for Lantus is called insulin glargine U-100. It’s the same product as Lantus, but without the brand name. This is also the case for unbranded Semglee, called insulin glargine-yfgn.
How to save on Lantus and Semglee
There are ways to save on Lantus and unbranded Semglee. GoodRx can help you navigate the ways to save on your insulin prescription.
How to save on Lantus
There are ways to save on Lantus, which is available as a reference (brand-name) biologic. GoodRx can help you navigate between GoodRx coupons, copay savings cards, and patient assistance programs to save money on your prescription.
Save with GoodRx. Anyone with a valid prescription, regardless of insurance status, can use GoodRx to purchase a 30-day supply of Lantus at an exclusive cash price of $35.
Save with a copay savings card. If you have commercial insurance, you may be eligible to pay as little as $35 per month for Lantus using a savings card from the manufacturer.
Save with a savings program: If you’re uninsured or paying cash for Lantus, you could pay as little as $35 through the Insulins Valyou Savings Program.
Save with a patient assistance program. If you’re uninsured or underinsured, you may be eligible for Lantus’ patient assistance program, which offers the medication free of charge.
How to save on unbranded Semglee
There are also ways to save on unbranded Semglee:
Save with GoodRx. With GoodRx, you could pay as little as $76.44 for unbranded Semglee at certain pharmacies.
Save with a copay savings card. If you have commercial insurance and meet eligibility requirements, unbranded Semglee’s price is as little as $0 with a savings card from the manufacturer.
Save with a free trial offer. If you’re new to unbranded Semglee, talk to your prescriber to see if you’re eligible for a free trial voucher for 5 pens or 2 vials.
Frequently asked questions
No, Semglee isn’t stronger than Lantus. Semglee is a biosimilar to Lantus, which means it’s highly similar and works just as well as Lantus.
Basaglar and Lantus aren’t exactly the same, but they both contain insulin glargine. Basaglar is considered a “follow-on” insulin to Lantus. This means it works in a very similar way and has comparable safety and effectiveness.
Even though they’re highly similar, Basaglar and Lantus aren’t automatically interchangeable at the pharmacy. If you’re interested in switching, your prescriber will need to write a new prescription.
Yes, brand-name Semglee insulin has been discontinued. But an unbranded version, called insulin glargine-yfgn, is still available. The unbranded product is exactly the same as Semglee, but without the brand name on the label.
No, Semglee isn’t stronger than Lantus. Semglee is a biosimilar to Lantus, which means it’s highly similar and works just as well as Lantus.
Basaglar and Lantus aren’t exactly the same, but they both contain insulin glargine. Basaglar is considered a “follow-on” insulin to Lantus. This means it works in a very similar way and has comparable safety and effectiveness.
Even though they’re highly similar, Basaglar and Lantus aren’t automatically interchangeable at the pharmacy. If you’re interested in switching, your prescriber will need to write a new prescription.
Yes, brand-name Semglee insulin has been discontinued. But an unbranded version, called insulin glargine-yfgn, is still available. The unbranded product is exactly the same as Semglee, but without the brand name on the label.
The bottom line
Lantus (insulin glargine) is a long-acting insulin that’s been around for a long time. Semglee (insulin glargine-yfgn) was approved in July 2021 as the first interchangeable biosimilar to Lantus. Brand-name Semglee has been discontinued, but an unbranded version is available. You can expect similar clinical benefits, side effects, and risks with both insulins. Factors such as cost and insurance coverage may help determine which is best for you.
Why trust our experts?


References
American Diabetes Association. (n.d.). Insulin basics for diabetes.
American Diabetes Association. (2020). Insulin is now a biologic—what does that mean?
ASHP. (2026). Drug shortage detail: Insulin glargine injection (recombinant).
Biocon Biologics Inc. (2025). Insulin glargine- insulin glargine-yfgn injection, solution [package insert]. DailyMed.
Hilgenfeld, R., et al. (2014). The evolution of insulin glargine and its continuing contribution to diabetes care. Drugs.
Mylan. (2020). Mylan and Biocon announce U.S. FDA approval of Semglee (insulin glargine injection).
Sanofi-Aventis. (2025). Lantus [package insert].











